Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L)
XGES.L is a passive ETF by DWS tracking the investment results of the MSCI World/Health Care NR USD. XGES.L launched on Jul 12, 2022 and has a 0.35% expense ratio.
ETF Info
| ISIN | IE000KD0BZ68 |
|---|---|
| WKN | DBX0R2 |
| Issuer | DWS |
| Inception Date | Jul 12, 2022 |
| Category | Health & Biotech Equities |
| Index Tracked | MSCI World/Health Care NR USD |
| Domicile | Ireland |
| Distribution Policy | Accumulating |
| Asset Class | Equity |
Asset Class Size | Mid-Cap |
Asset Class Style | Blend |
Expense Ratio
The Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C has a high expense ratio of 0.35%, indicating higher-than-average management fees.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: XGES.L vs. XDWT.L
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C had a return of -2.77% year-to-date (YTD) and -4.18% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -2.77% | 6.92% |
| 1 month | -4.99% | -2.83% |
| 6 months | 10.64% | 23.86% |
| 1 year | -4.18% | 23.33% |
| 5 years (annualized) | N/A | 11.66% |
| 10 years (annualized) | N/A | 10.52% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -1.59% | 4.06% | 0.83% | |||||||||
| 2023 | -5.01% | -9.56% | 5.15% | 9.18% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C(XGES.L)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGES.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C was 37.90%, occurring on Oct 30, 2023. The portfolio has not yet recovered.
The current Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C drawdown is 30.52%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -37.9% | Jul 20, 2022 | 323 | Oct 30, 2023 | — | — | — |
Volatility
Volatility Chart
The current Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C volatility is 5.47%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.